跳至主要内容
临床试验/DRKS00017626
DRKS00017626已完成1 期

Genotype-Phenotype-Correlation of Drug-Metabolising Enzymes - CYP-GP-COR-1

niversitätsklinikum Schleswig-Holstein (UKSH)0 个研究点目标入组 200 人开始时间: 2019年8月14日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • Age 18-55 years
  • Laboratory values in normal range: Elektrolytes (Na, K, Cl, Ca), Creatinin, Urea, Albumin, Hemoglobin, Hematokrit, INR <1.5
  • No severe pathologic findings in the cardiovascular, renal, pulmonal, hematopoetical, hepatic or neuronal system
  • No acute pathology during screening
  • Informed consent

排除标准

  • Known hypersensitivity to the probe drug cocktail
  • Laboratory values outside reference range (as judged by the investigator)
  • Contraception with hormonal contraceptives
  • Drug use within 3 days before phenotyping
  • Expected non-compliance
  • Other absolute and relative contraindications of the probe drugs
  • Other conditions that might render the subject inappropriate for this trial (as judged by the investigator)
  • Concurrent participation in another clinical trial

研究者

发起方
niversitätsklinikum Schleswig-Holstein (UKSH)

相似试验